Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity Due to Chemotherapy”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableLooking for participantsNCT06274268
What this trial is testing

Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments

Who this might be right for
SarcopeniaOncologyPhysical Inactivity+1 more
Centre Hospitalier Metropole Savoie 700
Testing effectiveness (Phase 2)Study completedNCT04737265
What this trial is testing

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

Who this might be right for
CardiotoxicityToxicity Due to ChemotherapyBreast Cancer+3 more
Abramson Cancer Center at Penn Medicine 108
Large-scale testing (Phase 3)UnknownNCT01999933
What this trial is testing

Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer

Who this might be right for
Cervical CancerToxicity Due to Radiotherapy
Mei Shi 600
Not applicableUnknownNCT01892852
What this trial is testing

Acupuncture for Chemotherapy-induced Peripheral Neuropathy

Who this might be right for
Peripheral NeuropathyToxicity Due to ChemotherapyLymphoma+1 more
Pusan National University Hospital 36
Not applicableUnknownNCT05927636
What this trial is testing

Systemic Treatment Related Toxicity Identified With a Smartphone APPlication Measuring Step Count

Who this might be right for
CancerSystemic TreatmentPhysical Activity+1 more
Radboud University Medical Center 411
Not applicableUnknownNCT02848807
What this trial is testing

Chemotherapy-related Toxicity, Nutritional Status and Quality of Life

Who this might be right for
Toxicity Due to ChemotherapyCancer CachexiaMetastatic Colorectal Cancer+2 more
University Clinical Centre, Gdansk 100
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Not applicableApproved For MarketingNCT01432301
What this trial is testing

Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination

Who this might be right for
Toxicity Due to Chemotherapy
Wellstat Therapeutics
Not applicableActive Not RecruitingNCT03199300
What this trial is testing

Investigating Cardiovascular Adverse Events Related to Cancer Treatment

Who this might be right for
Toxicity Due to ChemotherapyCardiovascular MorbidityCancer, Treatment-Related
University Medical Center Groningen 20
Not applicableUnknownNCT01493011
What this trial is testing

Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBToxicity Due to Chemotherapy
Xijing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT01596868
What this trial is testing

GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China

Who this might be right for
Nasopharyngeal Squamous Cell CarcinomaToxicity Due to Radiotherapy
Air Force Military Medical University, China 60
Not applicableStudy completedNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT04894123
What this trial is testing

Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients

Who this might be right for
Colorectal AdenocarcinomaOesogastric
GERCOR - Multidisciplinary Oncology Cooperative Group 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07032142
What this trial is testing

Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidote

Who this might be right for
CancerToxicity Due to Chemotherapy
D'Or Institute for Research and Education 66
Not applicableLooking for participantsNCT05885048
What this trial is testing

Impact of Gonadotoxic Therapies on Fertility

Who this might be right for
CancerFertility IssuesFertility Preservation+3 more
Michael von Wolff 7,000
Testing effectiveness (Phase 2)UnknownNCT04999332
What this trial is testing

Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaEffects of Chemotherapy+1 more
National Cheng-Kung University Hospital 58
Large-scale testing (Phase 3)UnknownNCT02856048
What this trial is testing

Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer

Who this might be right for
CancerToxicity Due to ChemotherapySarcoma+3 more
Assistance Publique - Hôpitaux de Paris 11
Not applicableUnknownNCT02934971
What this trial is testing

Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure

Who this might be right for
Toxicity Due to Chemotherapy
RWTH Aachen University 470
Testing effectiveness (Phase 2)Study completedNCT00771433
What this trial is testing

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeutropenia
Centre Francois Baclesse 120
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Next Page